Crescent Capital BDC, Inc. (NASDAQ:CCAP) Receives $19.17 Average PT from Brokerages

Crescent Capital BDC, Inc. (NASDAQ:CCAP – Get Free Report) has been given an average rating of “Moderate Buy” by the six ratings firms that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12-month […]

Leave a Reply

Your email address will not be published.

Previous post Inozyme Pharma, Inc. (NASDAQ:INZY) Receives $17.00 Average Price Target from Analysts
Next post Nordson Co. (NASDAQ:NDSN) Given Average Recommendation of “Moderate Buy” by Analysts